Cedar Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-356
| Closed | -$81.2K | – | 90 |
|
|
2025
Q4 | $81.2K | Hold |
356
| – | – | 0.02% | 107 |
|
|
2025
Q3 | $82.3K | Buy |
356
+1
| +0.3% | +$204 | 0.03% | 110 |
|
|
2025
Q2 | $66K | Buy |
355
+29
| +9% | +$5.39K | 0.02% | 107 |
|
|
2025
Q1 | $68.3K | Hold |
326
| – | – | 0.02% | 105 |
|
|
2024
Q4 | $57.9K | Sell |
326
-665
| -67% | -$122K | 0.02% | 102 |
|
|
2024
Q3 | $196K | Hold |
991
| – | – | 0.06% | 105 |
|
|
2024
Q2 | $170K | Hold |
991
| – | – | 0.06% | 109 |
|
|
2024
Q1 | $180K | Buy |
991
+65
| +7% | +$11.2K | 0.06% | 116 |
|
|
2023
Q4 | $144K | Sell |
926
-100
| -10% | -$14.6K | 0.05% | 118 |
|
|
2023
Q3 | $153K | Hold |
1,026
| – | – | 0.06% | 116 |
|
|
2023
Q2 | $138K | Hold |
1,026
| – | – | 0.05% | 118 |
|
|
2023
Q1 | $164K | Sell |
1,026
-432
| -30% | -$66K | 0.07% | 104 |
|
|
2022
Q4 | $236K | Sell |
1,458
-108
| -7% | -$16.6K | 0.12% | 87 |
|
|
2022
Q3 | $210K | Sell |
1,566
-54
| -3% | -$7.75K | 0.1% | 100 |
|
|
2022
Q2 | $248K | Hold |
1,620
| – | – | 0.11% | 94 |
|
|
2022
Q1 | $263K | Hold |
1,620
| – | – | 0.11% | 106 |
|
|
2021
Q4 | $219K | Sell |
1,620
-42
| -3% | -$4.96K | 0.09% | 117 |
|
|
2021
Q3 | $179K | Hold |
1,662
| – | – | 0.08% | 111 |
|
|
2021
Q2 | $187K | Buy |
1,662
+134
| +9% | +$15.1K | 0.08% | 109 |
|
|
2021
Q1 | $165K | Buy |
1,528
+828
| +118% | +$88.6K | 0.08% | 105 |
|
|
2020
Q4 | $75K | Hold |
700
| – | – | 0.04% | 121 |
|
|
2020
Q3 | $61K | Hold |
700
| – | – | 0.04% | 121 |
|
|
2020
Q2 | $69K | Hold |
700
| – | – | 0.05% | 116 |
|
|
2020
Q1 | $53K | Buy |
700
+100
| +17% | +$8.52K | 0.04% | 122 |
|
|
2019
Q4 | $53K | Hold |
600
| – | – | 0.03% | 88 |
|
|
2019
Q3 | $45K | Hold |
600
| – | – | 0.03% | 95 |
|
|
2019
Q2 | $44K | Buy |
+600
| New | +$47.2K | 0.03% | 110 |
|
|
2017
Q3 | – | Sell |
-40
| Closed | -$3K | – | 138 |
|
|
2017
Q2 | $3K | Hold |
40
| – | – | ﹤0.01% | 120 |
|
|
2017
Q1 | $3K | Hold |
40
| – | – | ﹤0.01% | 120 |
|
|
2016
Q4 | $3K | Hold |
40
| – | – | ﹤0.01% | 115 |
|
|
2016
Q3 | $3K | Hold |
40
| – | – | ﹤0.01% | 104 |
|
|
2016
Q2 | $2K | Sell |
40
-80
| -67% | -$4.88K | ﹤0.01% | 116 |
|
|
2016
Q1 | $7K | Buy |
+120
| New | +$6.69K | ﹤0.01% | 92 |
|
Other funds holding ABBV
VCM
VPM
Cedar Wealth Management's ABBV Position: Q1 2026 in Review
Cedar Wealth Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 356 shares — an estimated $81.2K sold.
Cedar Wealth Management first reported a position in ABBV in Q1 2016 and held it in 33 quarters. The position peaked at $263K in Q1 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Cedar Wealth Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
- Cedar Wealth Management sold 356 AbbVie shares in Q1 2026, an estimated $81.2K.
- Cedar Wealth Management first reported a position in AbbVie in Q1 2016 and held it in 33 quarters.
- Cedar Wealth Management's AbbVie position peaked at $263K in Q1 2022.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Cedar Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.